Literature DB >> 72125

Perinatal immunity to group B beta-hemolytic streptococcus type Ia.

P B Stewardson-Krieger, K Albrandt, T Nevin, R R Kretschmer, S P Gotoff.   

Abstract

Sera from 14 of 56 adult women protected mice from intraperitoneal challenge with mouse-virulent group B Streptococcus serotype Ia, and sera from seven of 25 nonparturient women in this group were bactericidal for greater than 99% of the organisms in the presence of normal polymorphonuclear leukocytes. There were no discrepancies between the in vivo and in vitro assays. Protective activity was found in the IgG class in seven sera, and in the IgM class in one. Opsonic activity was partially dependent on heat-labile serum factors. Of 31 mother-cord serum pairs studied, seven maternal sera were protective, but four of the corresponding cord sera were not. Pooled human gamma-globulin injected by either the intraperitoneal or the intramuscular route protected mice from bacterial challenge.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72125     DOI: 10.1093/infdis/136.5.649

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Immunological aspects of group B streptococcal infections.

Authors:  R R Kretschmer; S P Gotoff
Journal:  Infection       Date:  1978       Impact factor: 3.553

2.  Passive protection by human sera in mice against challenge with strains of group B streptococci.

Authors:  Y Ichiman; K Yoshida
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections.

Authors:  S P Gotoff
Journal:  Infection       Date:  1985       Impact factor: 3.553

4.  Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody.

Authors:  B F Anthony; N F Concepcion; S A McGeary; J I Ward; D C Heiner; P Shapshak; R A Insel
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

5.  Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections.

Authors:  S P Gotoff
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

6.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

7.  Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.

Authors:  G W Fischer; S R Wilson; K W Hunter
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

9.  Group B streptococcal long-chain reaction.

Authors:  P Stewardson-Krieger; K Albrandt; R R Kretschmer; S P Gotoff
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Protection of mice against group B Streptococcus type Ia by IgG components of a rabbit antiserum.

Authors:  P H Cleat; C R Coid
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.